Skip to main content
. 2022 Feb 16;2022(2):CD007929. doi: 10.1002/14651858.CD007929.pub4

2.2. Analysis.

2.2

Comparison 2: Newly diagnosed EOC: PARPi with chemotherapy and as maintenance therapy compared with chemotherapy alone, Outcome 2: Progression‐free survival by BRCA status